###begin article-title 0
GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions
###end article-title 0
###begin p 1
###xml 280 284 280 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
The contribution of intimal cell proliferation to the formation of early atherosclerotic lesions is poorly understood. We combined 5-bromo-2'-deoxyuridine pulse labeling with sensitive en face immunoconfocal microscopy analysis, and quantified intimal cell proliferation and Ly-6Chigh monocyte recruitment in low density lipoprotein receptor-null mice. Cell proliferation begins in nascent lesions preferentially at their periphery, and proliferating cells accumulate in lesions over time. Although intimal cell proliferation increases in parallel to monocyte recruitment as lesions grow, proliferation continues when monocyte recruitment is inhibited. The majority of proliferating intimal cells are dendritic cells expressing CD11c and major histocompatibility complex class II and 33D1, but not CD11b. Systemic injection of granulocyte/macrophage colony-stimulating factor (GM-CSF) markedly increased cell proliferation in early lesions, whereas function-blocking anti-GM-CSF antibody inhibited proliferation. These findings establish GM-CSF as a key regulator of intimal cell proliferation in lesions, and demonstrate that both proliferation and monocyte recruitment contribute to the inception of atherosclerosis.
###end p 1
###begin p 2
###xml 159 178 159 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Sk&#229;l&#233;n et al., 2002</xref>
###xml 432 455 432 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Moore and Freeman, 2006</xref>
###xml 526 546 526 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Mullick et al., 2008</xref>
###xml 604 624 604 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Swirski et al., 2006</xref>
###xml 626 644 626 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Tacke et al., 2007</xref>
###xml 495 500 <span type="species:ncbi:10090">mouse</span>
In atherosclerosis, serum lipoproteins, particularly low density lipoprotein (LDL), accumulate in the arterial intima through binding to matrix proteoglycans (Skalen et al., 2002) and undergo oxidative modification. Blood monocytes are recruited into these regions of the intima, differentiate into macrophages or DCs, and internalize oxidatively modified lipoproteins via scavenger receptors or by macropinocytosis (for review see Moore and Freeman, 2006). BM-derived cells accumulate in early mouse atherosclerotic lesions (Mullick et al., 2008), and monocyte recruitment persists in advanced lesions (Swirski et al., 2006; Tacke et al., 2007).
###end p 2
###begin p 3
###xml 178 206 178 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Grage-Griebenow et al., 2001</xref>
###xml 208 230 208 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Geissmann et al., 2003</xref>
###xml 251 255 251 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 363 383 363 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Swirski et al., 2007</xref>
###xml 385 403 385 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Tacke et al., 2007</xref>
###xml 411 415 411 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 546 549 546 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 724 728 724 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 818 821 818 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 932 950 932 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Tacke et al., 2007</xref>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
Circulating monocytes consist of at least two subpopulations, with distinct expression of cell-surface markers, chemokine receptors, and functions during inflammatory responses (Grage-Griebenow et al., 2001; Geissmann et al., 2003). In mice, the Ly-6Chigh subset is elevated during hypercholesterolemia and is preferentially recruited to atherosclerotic lesions (Swirski et al., 2007; Tacke et al., 2007). Ly-6Chigh monocytes express abundant L-selectin and multiple chemokine receptors, including CCR2, but relatively low levels of CX3CR1. Ly-6Clow monocytes express higher levels of CX3CR1, and low to nondetectable levels of most chemokine receptors, L-selectin and Ly-6C. Thus, it is intriguing that recruitment of Ly-6Chigh monocytes to lesions is dependent on CCR2, CCR5, and CX3CR1, whereas recruitment of Ly-6Clow monocytes is independent of CX3CR1 and dependent on CCR5, which is up-regulated in hypercholesterolemic mice (Tacke et al., 2007).
###end p 3
###begin p 4
###xml 435 453 435 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Smith et al., 1995</xref>
###xml 455 472 455 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Qiao et al., 1997</xref>
###xml 749 774 749 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Ditiatkovski et al., 2006</xref>
###xml 776 799 776 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Shaposhnik et al., 2007</xref>
###xml 883 884 883 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 903 926 903 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Shaposhnik et al., 2007</xref>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 709 714 <span type="species:ncbi:10090">mouse</span>
Fatty streaks are composed almost entirely of myeloid foam cells, and their formation and lateral expansion are critically dependent on monocytes/macrophages. This was demonstrated using osteopetrotic mice that have a point mutation that disrupts M-CSF and are deficient in circulating monocytes, tissue macrophages, and osteoclasts. Osteopetrotic mice are highly protected from atherosclerosis in the setting of hypercholesterolemia (Smith et al., 1995; Qiao et al., 1997), and these studies implicate monocytes and their progeny as key cells in lesion development. In contrast to M-CSF, deficiency of GM-CSF has no significant effects on circulating monocytes or tissue macrophages, and variable effects on mouse atherosclerotic lesion formation (Ditiatkovski et al., 2006; Shaposhnik et al., 2007). An interesting feature in the setting of GM-CSF deficiency is a decrease of CD11c+ cells in lesions (Shaposhnik et al., 2007).
###end p 4
###begin p 5
###xml 216 240 216 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Rosenfeld and Ross, 1990</xref>
###xml 242 262 242 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Orekhov et al., 1998</xref>
###xml 264 284 264 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Merched et al., 2003</xref>
###xml 376 379 376 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 372 379 372 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe<sup>&#8722;/&#8722;</sup></italic>
###xml 387 407 387 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Lessner et al., 2002</xref>
###xml 845 849 845 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 184 189 <span type="species:ncbi:9606">human</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 795 800 <span type="species:ncbi:10090">mouse</span>
The biology of macrophages and DCs in atherosclerotic lesions is complex. These cells can proliferate or undergo apoptosis, and both processes have been observed primarily in advanced human and experimental lesions (Rosenfeld and Ross, 1990; Orekhov et al., 1998; Merched et al., 2003) and in a vascular occlusion model in hypercholesterolemic apolipoprotein E-deficient (Apoe-/-) mice (Lessner et al., 2002). The prevailing opinion is that monocyte recruitment accounts for the formation of early lesions, and the relationship of proliferation to monocyte recruitment is not understood. A key impediment has been the lack of a sensitive approach to study cell proliferation and monocyte recruitment in early lesions. We used BrdU pulse labeling combined with en face confocal microscopy of the mouse aorta to detect cell proliferation and Ly-6Chigh monocyte recruitment, and localize them with respect to lipid accumulation in the intima. We found that intimal cell proliferation begins in nascent lesions preferentially at the periphery, increases as lesions progress in parallel to monocyte recruitment, primarily involves DCs, and is dependent on GM-CSF but not monocyte recruitment.
###end p 5
###begin title 6
RESULTS AND DISCUSSION
###end title 6
###begin title 7
###xml 47 51 47 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
BrdU pulse labeling preferentially labels Ly-6Chigh blood monocytes
###end title 7
###begin p 8
###xml 178 200 178 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Kriss and Revesz, 1962</xref>
###xml 321 338 321 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Goto et al., 2003</xref>
###xml 340 367 340 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Jongstra-Bilen et al., 2006</xref>
###xml 482 490 482 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 a</xref>
###xml 497 498 497 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 504 508 504 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 513 517 513 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 598 606 598 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 b</xref>
###xml 627 628 627 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 634 638 634 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 745 753 745 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 b</xref>
###xml 803 807 803 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 827 828 827 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 835 838 835 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 843 847 843 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 963 967 963 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 972 976 972 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1071 1079 1071 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 c</xref>
###xml 1110 1111 1110 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1117 1121 1117 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
BrdU is stably incorporated into the DNA of cells during the S phase of the cell cycle. Pulse labeling is achieved because injected BrdU is cleared from the plasma within hours (Kriss and Revesz, 1962). BrdU labels proliferating monocyte precursors in the BM, and labeled monocytes appear in the circulation after 4-6 h (Goto et al., 2003; Jongstra-Bilen et al., 2006). We used flow cytometry to investigate BrdU labeling of BM and blood monocyte subsets in wild-type C57BL/6 mice (Fig. 1 a). BrdU+ Ly-6ChighCD115high cells were detected in the BM at 2 h, increased, and reached a plateau at 12 h (Fig. 1 b). In the blood, BrdU+ Ly-6Chigh monocytes were not detected within 6 h but increased rapidly thereafter and reached a plateau at 12-24 h (Fig. 1 b), at which time 35-45% of circulating blood Ly-6Chigh monocytes were BrdU+. Ly-6CnegCD115high BM cells and blood monocytes did not stain for BrdU. The mean fluorescence intensity (MFI) of BM BrdU-labeled Ly-6ChighCD115high cells declined over time, consistent with ongoing rapid proliferation of monocyte precursors (Fig. 1 c). In contrast, the MFI of BrdU+ Ly-6Chigh blood monocytes remained relatively stable over 24 h.
###end p 8
###begin p 9
###xml 0 96 0 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Analysis of BrdU pulse-labeled monocyte subpopulations in the BM and blood using flow cytometry.</bold>
###xml 373 374 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 602 606 602 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 672 676 672 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 713 714 713 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 819 820 819 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 826 830 826 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 840 843 840 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 1003 1004 1003 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1010 1014 1010 1014 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1199 1203 1197 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1213 1216 1211 1214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 1264 1267 1262 1265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1260 1267 1258 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 1503 1506 1501 1504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1499 1506 1497 1504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 1568 1569 1562 1563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1728 1729 1720 1721 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1735 1739 1727 1731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1813 1816 1805 1808 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1809 1816 1801 1808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 151 156 <span type="species:ncbi:10090">mouse</span>
###xml 900 904 <span type="species:ncbi:10090">mice</span>
###xml 1145 1149 <span type="species:ncbi:10090">mice</span>
###xml 1251 1255 <span type="species:ncbi:10090">mice</span>
###xml 1268 1272 <span type="species:ncbi:10090">mice</span>
###xml 1527 1531 <span type="species:ncbi:10090">mice</span>
###xml 1672 1676 <span type="species:ncbi:10090">mice</span>
###xml 1800 1804 <span type="species:ncbi:10090">mice</span>
###xml 1817 1821 <span type="species:ncbi:10090">mice</span>
###xml 1928 1932 <span type="species:ncbi:10090">mice</span>
###xml 2077 2081 <span type="species:ncbi:10090">mice</span>
Analysis of BrdU pulse-labeled monocyte subpopulations in the BM and blood using flow cytometry. (a, left) A dot plot of a blood sample from a C57BL/6 mouse obtained 18 h after BrdU injection illustrates identification of monocyte subsets. Typically, >85% of events were gated in forward versus side scatter analysis (not depicted). Monocytes expressed high levels of CD115+, and subpopulations were identified based on high, low, and negative (neg) expression levels of Ly-6C. Neutrophils (N), expressing low levels of CD115 and intermediate levels of Ly-6C, served as a landmark for setting the Ly-6Chigh gate. (right) A histogram of BrdU fluorescence gated on the Ly-6Chigh cells indicated that 50.6% were BrdU+. Representative data from one out of three independent experiments is shown. (b) The percentages of BrdU+ Ly-6Chigh and Ly-6Cneg monocytes in the BM (left) and blood (right) of C57BL/6 mice are plotted at different time points after BrdU injection. (c) A time course shows the MFI of BrdU+ Ly-6Chigh monocytes in the BM and blood. In b and c, three independent experiments were performed and means +/- SEM were derived from three mice per time point. (d) The absolute numbers of Ly-6Chigh and Ly-6Cneg monocytes in the blood of C57BL/6 mice and Ldlr-/- mice fed a CRD for 2 wk are plotted. They were derived from total blood leukocyte counts, and the percentage of each monocyte subpopulation was determined by flow cytometry. The total blood leukocyte count was elevated 1.5-fold in Ldlr-/- relative to C57BL/6 mice (8.94 +/- 0.75 vs. 5.8 +/- 0.38 x 106 cells/ml; three and two independent experiments, respectively). Means +/- SEM were derived from eight mice per genotype (*, P < 0.005). (e) Percentage of BrdU+ Ly-6Chigh monocytes in the blood after BrdU pulse labeling of C57BL/6 mice and Ldlr-/- mice fed a CRD for 2 wk (three independent experiments for each genotype with means +/- SEM derived from three mice per time point). The asterisk indicates a statistically significant difference (P < 0.03) between hypercholesterolemic and normocholesterolemic mice when data from the 12, 18, and 24 h time points were combined (53.3 +/- 3.2% vs. 38.5 +/- 4.8%).
###end p 9
###begin p 10
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe<sup>&#8722;/&#8722;</sup></italic>
###xml 302 306 302 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 365 385 365 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Swirski et al., 2007</xref>
###xml 387 405 387 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Tacke et al., 2007</xref>
###xml 561 564 561 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 557 564 557 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 649 653 649 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 694 702 694 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 d</xref>
###xml 735 738 735 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg</sup>
###xml 807 815 807 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 d</xref>
###xml 872 876 872 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1114 1122 1114 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 e</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
###xml 937 941 <span type="species:ncbi:10090">mice</span>
###xml 1051 1055 <span type="species:ncbi:10090">mice</span>
Wild-type mice are resistant to developing diet-induced hypercholesterolemia and atherosclerosis. In atherosclerosis-susceptible Apoe-/- mice, prolonged and marked hypercholesterolemia as a result of feeding a high fat diet for 12-25 wk induced a substantial increase in the number of circulating Ly-6Chigh monocytes, which are preferentially recruited to plaques (Swirski et al., 2007; Tacke et al., 2007). The effects of short-term hypercholesterolemia on monocyte release from the BM and circulating monocyte levels is unknown. We fed LDL receptor-null (Ldlr-/-) mice a cholesterol-rich diet (CRD) for just 2 wk and found that the number of Ly-6Chigh blood monocytes was increased 2.9-fold (Fig. 1 d). In contrast, circulating Ly-6Cneg monocytes were not significantly increased by hypercholesterolemia (Fig. 1 d). There was a trend toward higher BrdU labeling of Ly-6Chigh blood monocytes at 12, 18, and 24 h in hypercholesterolemic mice, and a statistically significant difference (P < 0.03) between hypercholesterolemic and normocholesterolemic mice was found when data from these time points were combined (Fig. 1 e).
###end p 10
###begin title 11
###xml 144 148 144 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
Proliferation of intimal leukocytes increases progressively from the inception of atherosclerosis in parallel to recruitment of BM-derived Ly-6Chigh monocytes
###end title 11
###begin p 12
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 126 149 126 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Ishibashi et al., 1994a</xref>
###xml 151 172 151 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Lichtman et al., 1999</xref>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 277 284 277 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 361 369 361 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 a</xref>
###xml 486 487 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 536 544 536 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 e</xref>
###xml 551 552 551 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 680 684 680 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 761 788 761 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Jongstra-Bilen et al., 2006</xref>
###xml 838 842 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 842 845 842 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 911 912 911 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 921 929 921 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 b</xref>
###xml 945 946 945 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1051 1055 1049 1053 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1112 1139 1110 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Jongstra-Bilen et al., 2006</xref>
###xml 1149 1152 1147 1150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1145 1152 1143 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 1189 1197 1187 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 b</xref>
###xml 1233 1234 1231 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1479 1482 1473 1476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1475 1482 1469 1476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 1516 1517 1510 1511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1794 1797 1788 1791 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1790 1797 1784 1791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 1839 1840 1833 1834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 832 836 <span type="species:ncbi:10090">mice</span>
###xml 1153 1157 <span type="species:ncbi:10090">mice</span>
###xml 1302 1306 <span type="species:ncbi:10090">mice</span>
###xml 1483 1487 <span type="species:ncbi:10090">mice</span>
###xml 1798 1802 <span type="species:ncbi:10090">mice</span>
Feeding Ldlr-/- mice a CRD initiates a marked hypercholesterolemia and atherosclerotic lesion formation throughout the aorta (Ishibashi et al., 1994a; Lichtman et al., 1999). As early as 1 wk after CRD feeding, nascent lesions were detected in the lesser curvature (LC) of the Ldlr-/- ascending aorta, and lesion surface area increased progressively with time (Fig. 2 a). Cell proliferation in the ascending aortic intima was examined 2 h after injection of BrdU, a time point when BrdU+ monocytes were not detected in the circulation (Fig. 1 e). BrdU+ nuclei were also quantified 24 h after BrdU injection when proliferating intimal cells as well as BM-derived BrdU-labeled Ly-6Chigh monocytes recruited from the blood are detected. As we reported previously (Jongstra-Bilen et al., 2006), in the ascending aorta of normal C57BL/6 mice (Ldlr+/+), we found very low proliferation at 2 h only in the LC (0.5 BrdU+ nuclei; Fig. 2 b). At 24 h, BrdU+ nuclei increased by 20-fold to 10.3 +/- 2.3 nuclei, which represents mostly recruited BrdU-labeled Ly-6Chigh monocytes and is consistent with our previous findings (Jongstra-Bilen et al., 2006). In Ldlr-/- mice fed a standard chow diet (SCD; Fig. 2 b, time point 0), the numbers of BrdU+ nuclei at 2 and 24 h were virtually identical to wild-type C57BL/6 mice (0.5 +/- 0.3 and 10 +/- 2, respectively), indicating relatively comparable baseline rates of cell proliferation and monocyte recruitment to the intima. After switching Ldlr-/- mice to a CRD, the number of BrdU+ nuclei at 2 and 24 h progressively increased, which demonstrates a parallel increase in both intimal cell proliferation and monocyte recruitment from the inception of atherosclerosis. At 2 wk of CRD, intimal cell proliferation increased by 40-fold relative to C57BL/6 and Ldlr-/- mice fed a SCD, and the abundance of BrdU+ nuclei detected at 24 h increased by approximately 8-fold.
###end p 12
###begin p 13
###xml 0 132 0 132 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Quantification of lipid accumulation, intimal cell proliferation, and monocyte recruitment during the initiation of atherosclerosis.</bold>
###xml 193 196 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 189 196 189 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 659 662 657 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 655 662 653 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 708 709 706 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 794 797 792 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 790 797 788 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>+/+</sup></italic>
###xml 814 817 812 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 810 817 808 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 960 961 958 959 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1172 1175 1168 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1168 1175 1164 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 1385 1388 1381 1384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1381 1388 1377 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 1457 1458 1453 1454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1707 1710 1703 1706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1703 1710 1699 1706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 1769 1770 1765 1766 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
###xml 784 788 <span type="species:ncbi:10090">mice</span>
###xml 818 822 <span type="species:ncbi:10090">mice</span>
###xml 1124 1128 <span type="species:ncbi:10090">mice</span>
###xml 1176 1180 <span type="species:ncbi:10090">mice</span>
###xml 1389 1394 <span type="species:ncbi:10090">mouse</span>
###xml 1711 1716 <span type="species:ncbi:10090">mouse</span>
Quantification of lipid accumulation, intimal cell proliferation, and monocyte recruitment during the initiation of atherosclerosis. (a) En face fluorescent images of ascending aortas from Ldlr-/- mice fed a CRD for 1, 2, or 3 wk. Intimal lipid accumulation was visualized (red; top), and the lesion areas relative to the value for the 3-wk CRD group (dashed line) were determined (bottom). Means +/- SEM were derived from 4 (1 wk), 22 (2 wk), and 6 (3 wk) mice studied in 2, 11, and 3 independent experiments, respectively. A representative image is shown for each time point. Note that lipid accumulation was detected in the LC but not in the GC, or in Ldlr-/- mice fed SCD (not depicted). (b) Intimal BrdU+ nuclei were enumerated at 2 and 24 h after BrdU pulse labeling in C57BL/6 mice (Ldlr+/+) fed SCD or Ldlr-/- mice fed a CRD (0-3 wk). The entire surface of the ascending aorta above the aortic valve was scanned by en face confocal microscopy, but BrdU+ nuclei were detected only in the LC. For each time point, four to seven independent experiments were performed, and means +/- SEM were derived from four to seven mice (*, P < 0.05; **, P < 0.01 relative to Ldlr-/- mice fed SCD, i.e., 0 wk of CRD). (c) A composite of en face images taken with a 16x objective shows the entire oil red O-stained lesion area (red) in the LC of the ascending aortic arch harvested from an Ldlr-/- mouse that was fed a CRD for 2 wk and pulsed for 2 h with BrdU. BrdU+ nuclei (green) are primarily at the periphery of the lesion. Inset (top left) shows a high power image of the region indicated with dashed lines. Nuclei are blue. (d and e) En face confocal images of the ascending aortic arch harvested from an Ldlr-/- mouse fed CRD for 2 wk and pulsed with BrdU for 24 h. BrdU+ nuclei and lipid accumulated in the LC (d) but not in the GC (e). Images in c, d, and e are representative of at least four independent experiments. Bars: (a) 1 mm; (c-e) 20 microm.
###end p 13
###begin p 14
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 41 56 41 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, d and e</xref>
###xml 150 165 146 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, c and d</xref>
All BrdU+ nuclei were located in the LC (Fig. 2, d and e) and many (88 +/- 4% and 66 +/- 12% at 2 and 24 h, respectively) were at borders of lesions (Fig. 2, c and d), suggesting that cell proliferation and monocyte recruitment occur in similar regions. Proliferating intimal cells at borders of lesions were often adjacent to cells containing lipid droplets, and their nuclei extended below the endothelial cell monolayer ().
###end p 14
###begin title 15
Proliferating intimal cells accumulate in 2-wk atherosclerotic lesions
###end title 15
###begin p 16
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 132 140 132 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 e</xref>
###xml 155 156 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 406 407 406 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
BrdU labeling in lesions was initially studied within 6 h of BrdU injection, when minimal BrdU+ monocytes are released from the BM (Fig. 1 e). Intimal BrdU+ nuclei were detected at 1 h, increased at 2 and 3 h, and then remained stable (Fig. S1 d). This suggests that the BrdU labeling window is <3 h. Another possibility is that labeled intimal cells complete mitosis within 3 h. Consistent with this, BrdU+ nuclear doublets that likely represent daughter cells also increased within 3 h (Fig. S1, e and f).
###end p 16
###begin p 17
###xml 465 483 461 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Smith et al., 2004</xref>
###xml 654 662 650 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 a</xref>
###xml 776 794 772 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Smith et al., 2004</xref>
###xml 1004 1005 996 997 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
Proliferating intimal cells may divide to produce two daughter cells or, alternatively, may undergo apoptosis. The fate of proliferating intimal cells was investigated by inhibiting blood monocyte recruitment with pertussis toxin (PTx). PTx inactivates Galphai chemokine receptors and has been used in vivo to study the contribution of chemokine receptors versus E-selectin-triggered integrin activation in neutrophil recruitment to the inflamed peritoneal cavity (Smith et al., 2004). We found that PTx markedly diminished monocyte recruitment at 24 h to thioglycollate-inflamed peritoneal cavity despite a marked increase in circulating myeloid cells (Fig. 3 a and ). In contrast, PTx reduced but did not eliminate neutrophil recruitment, consistent with a previous report (Smith et al., 2004). These data illustrate an important difference in monocytes versus neutrophil signaling. As was shown previously, neutrophil binding to E-selectin induces a compensatory signaling pathway that bypasses Galphai signaling irreversibly blocked by PTx, whereas our data suggest that this compensatory pathway is not operative in monocytes.
###end p 17
###begin p 18
###xml 0 176 0 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTx blockade of monocyte recruitment reveals that proliferating intimal cells accumulate in 2-wk lesions, and intimal cell proliferation is independent of monocyte recruitment.</bold>
###xml 482 485 482 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 478 485 478 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 668 669 668 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 702 705 702 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 698 705 698 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 851 852 851 852 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 994 998 <span type="species:ncbi:10090">mice</span>
PTx blockade of monocyte recruitment reveals that proliferating intimal cells accumulate in 2-wk lesions, and intimal cell proliferation is independent of monocyte recruitment. (a) Flow cytometry plots of peritoneal exudate cells harvested 24 h after i.p. thioglycollate injection of control and PTx-treated mice (percentages are indicated). Representative data from five mice per group studied in two independent experiments are shown. Additional details are provided in . (b) Ldlr-/- mice fed a CRD for 2 wk were injected with BrdU at 2 h before treatment with PTx or PBS (C, control). Aortas were harvested 24 h (left) and 2 h (right) after BrdU injection, and BrdU+ nuclei were enumerated. (c) Ldlr-/- mice fed a CRD for 2 wk were injected with PTx, and BrdU pulse labeling was performed 22 or 46 h later. Aortas were harvested after 2 h, and BrdU+ nuclei were enumerated. In b and c, four independent experiments were performed at each time point, and means +/- SEM were derived from four mice per group. *, P < 0.05 relative to C; **, P < 0.01.
###end p 18
###begin p 19
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 3 10 3 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 129 137 125 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 b</xref>
###xml 233 234 227 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 306 307 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
In Ldlr-/- mice fed a CRD for 2 wk, PTx significantly diminished the number of BrdU+ nuclei at 24 h from 86 +/- 10 to 26 +/- 12 (Fig. 3 b), consistent with PTx blockade of monocyte recruitment. In a parallel experiment, 21 +/- 2 BrdU+ nuclei representing intimal cells were detected at 2 h. Comparable BrdU+ nuclei (26 +/- 12) were detected in the PTx experiment at 24 h, suggesting that proliferating intimal cells persist and accumulate in lesions.
###end p 19
###begin title 20
Intimal cell proliferation is independent of monocyte recruitment
###end title 20
###begin p 21
###xml 231 239 231 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 c</xref>
Intimal cell proliferation in 2-wk lesions was determined by 2-h BrdU labeling after inhibition of monocyte recruitment for 22 or 46 h with PTx. Proliferation was not decreased by PTx at 22-24 h and, in fact, increased at 46-48 h (Fig. 3 c), which may represent a compensatory increase in cell proliferation in response to diminished blood monocyte recruitment. These data reveal that proliferating intimal cells are not newly recruited blood monocytes.
###end p 21
###begin title 22
Proliferating intimal cells express DC markers
###end title 22
###begin p 23
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 181 182 181 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 207 208 207 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 337 345 337 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 b</xref>
###xml 352 353 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 416 431 416 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, a and b</xref>
###xml 481 485 481 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 518 519 518 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 631 632 631 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 711 712 711 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Immunostaining for various leukocyte markers was performed to determine the phenotype of BrdU+ cells in atherosclerotic lesions. The majority of foam cells in 2-wk lesions are CD11c+ and CD68+, whereas CD11b+ cells are located in clusters (). After 2 or 24 h of BrdU labeling, >90% of BrdU+ cells expressed CD45, a pan-leukocyte marker (Fig. 4 b). BrdU+ cells costained predominantly with CD11b 24 h after labeling (Fig. 4, a and b), consistent with recruitment to lesions of Ly-6Chigh blood monocytes, which are CD11b+. More than 90% of proliferating cells (2 h of BrdU labeling) costained for CD11c, a DC marker, and >60% of BrdU+ cells expressed CD11c at 24 h, consistent with survival of proliferating CD11c+ cells.
###end p 23
###begin p 24
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression of leukocyte markers by BrdU<sup>+</sup> cells in early atherosclerotic lesions.</bold>
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 91 98 91 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 436 437 436 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 563 564 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 701 702 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 724 727 724 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 720 727 720 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 972 973 972 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1063 1064 1063 1064 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1131 1132 1131 1132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1352 1355 1352 1355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1348 1355 1348 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 728 732 <span type="species:ncbi:10090">mice</span>
###xml 1246 1250 <span type="species:ncbi:10090">mice</span>
###xml 1356 1360 <span type="species:ncbi:10090">mice</span>
###xml 1639 1643 <span type="species:ncbi:10090">mice</span>
Expression of leukocyte markers by BrdU+ cells in early atherosclerotic lesions. (a and b) Ldlr-/- mice fed a CRD for 2 wk were injected with BrdU at 2 or 24 h before harvesting of the ascending aorta. (a) Immunostaining for BrdU (green) was performed in conjunction with CD11b (red), CD11c (red), or CD45 (not depicted), and tissues were examined by en face confocal microscopy. Nuclei are blue. Arrowheads indicate representative BrdU+ cells that costained with CD11b or CD11c (closed) and those that were not costained (open). (b) Quantitative analysis of BrdU+ intimal cells that costained with CD45, CD11b, or CD11c at 2 and 24 h after labeling. Data are expressed as the percentage of total BrdU+ cells. (c and d) Ldlr-/- mice fed a CRD for 2 wk were injected with BrdU 2 h before harvesting of the ascending aorta. (c) Immunostaining for BrdU (green) and CD11c (yellow) was performed in conjunction with CD11b, CD68, or MHC II (red). Closed arrowheads indicate BrdU+ cells that costained with CD11c and CD11b, CD68, or MHC II; open arrowheads indicate BrdU+ cells costained only with CD11c. (d) Quantitative analysis of BrdU+ intimal cells that costained with the indicated markers. (e) Images of the ascending arch LC from normal C57BL/6 mice costained for CD11c (green) and 33D1 (red; arrowheads). (f) Images of the ascending arch LC from Ldlr-/- mice fed a CRD for 2 wk and injected with BrdU at 2 h before harvesting costained for BrdU (green), CD11c (yellow), and 33D1 (red; arrowheads). All images are representative of four independent experiments. In b and d, means +/- SEM of four independent experiments are plotted (four mice per group; **, P < 0.01; ***, P < 0.001). Bars, 20 microm.
###end p 24
###begin p 25
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 146 147 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 230 245 230 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, c and d</xref>
###xml 290 291 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 316 317 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 322 323 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 367 382 367 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, c and d</xref>
###xml 440 448 440 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 f</xref>
###xml 494 518 494 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Nussenzweig et al., 1982</xref>
###xml 520 535 520 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Xu et al., 2007</xref>
###xml 599 607 599 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 e</xref>
###xml 832 849 832 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Choi et al., 2009</xref>
###xml 990 1017 990 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Jongstra-Bilen et al., 2006</xref>
###xml 1019 1036 1019 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Choi et al., 2009</xref>
###xml 483 488 <span type="species:ncbi:10090">mouse</span>
###xml 586 591 <span type="species:ncbi:10090">mouse</span>
The expression of additional myeloid and DC markers by proliferating cells in 2-wk lesions was evaluated. 2 h after BrdU labeling, most BrdU+CD11c+ cells costained with CD68, a marker expressed by monocytes, macrophages, and DCs (Fig. 4, c and d; and ). Relatively low costaining with CD11b+ was confirmed. Many BrdU+CD11c+ cells costained with MHC class II (MHC II; Fig. 4, c and d; and Fig. S4), which is expressed by DCs, and with 33D1 (Fig. 4 f), a mAb that specifically targets mouse DCs (Nussenzweig et al., 1982; Xu et al., 2007). 33D1 stained resident intimal DCs in the normal mouse aorta (Fig. 4 e). Collectively, our data indicate that the majority of proliferating intimal cells in early atherosclerotic lesions express DC markers and, thus, may be capable of DC functions analogous to intimal DCs in the normal intima (Choi et al., 2009). Proliferating cells in early lesions may originate from intimal DCs residing in atherosclerosis-predisposed regions of the normal intima (Jongstra-Bilen et al., 2006; Choi et al., 2009) and/or recruited monocytes that differentiated in lesions to express DC markers after several days.
###end p 25
###begin title 26
GM-CSF is a critical regulator of cell proliferation in early atherosclerotic lesions
###end title 26
###begin p 27
###xml 170 197 170 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Hamilton and Anderson, 2004</xref>
###xml 260 285 260 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Rajavashisth et al., 1990</xref>
###xml 383 406 383 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Ishibashi et al., 1994b</xref>
###xml 481 484 481 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 477 484 477 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 515 538 515 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Shaposhnik et al., 2007</xref>
###xml 556 559 556 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 552 559 552 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe<sup>&#8722;/&#8722;</sup></italic>
###xml 586 611 586 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Ditiatkovski et al., 2006</xref>
###xml 684 685 684 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 687 693 687 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 743 744 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 763 786 763 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Shaposhnik et al., 2007</xref>
###xml 451 456 <span type="species:ncbi:10090">mouse</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
GM-CSF is a myeloid growth factor that induces DC differentiation from BM precursors and monocytes, and regulates the properties of mature myeloid cells in inflammation (Hamilton and Anderson, 2004). Modified LDL induces endothelial cell expression of GM-CSF (Rajavashisth et al., 1990), and GM-CSF down-regulates serum cholesterol while up-regulating VLDL receptor mRNA expression (Ishibashi et al., 1994b). GM-CSF deficiency has variable effects on mouse atherosclerosis. In Ldlr-/- mice, lesions were decreased (Shaposhnik et al., 2007), whereas in Apoe-/- mice they were increased (Ditiatkovski et al., 2006). Because the majority of proliferating cells in early lesions are CD11c+ (Fig. 3) and GM-CSF deficiency results in decreased CD11c+ cells in lesions (Shaposhnik et al., 2007), we investigated whether GM-CSF regulates cell proliferation in atherosclerotic lesions.
###end p 27
###begin p 28
###xml 143 146 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 139 146 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 241 259 226 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Rosas et al., 2007</xref>
###xml 550 558 531 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 a</xref>
###xml 1023 1024 996 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1069 1077 1042 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 b</xref>
###xml 1197 1198 1170 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1366 1374 1339 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 c</xref>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 979 984 <span type="species:ncbi:10090">mouse</span>
Initial experiments used real-time PCR to investigate mRNA expression of the GM-CSF receptor alpha chain (GMRalpha) in 2-wk-old lesions of Ldlr-/- mice. GMRalpha is specific for GM-CSF, unlike the beta chain that is shared by IL-3 and IL-5 (Rosas et al., 2007). The LC intima of the ascending aortic arch, which contains lesions, was compared with the nondiseased greater curvature (GC), a region that is protected from atherosclerotic lesion development. Expression of GMRalpha was markedly elevated in lesions relative to the uninvolved GC intima (Fig. 5 a). There was also enrichment of DCs and myeloid cell markers (CD11c and CD68) in lesions, but expressions of T cell (CD3), smooth muscle cell (SM22alpha), and endothelial cell (CD31 and intercellular adhesion molecule 2) markers were comparable. Having established that GMRalpha is expressed in 2-wk lesions, two complementary experiments directly evaluated the role of GM-CSF in intimal cell proliferation. Injection of mouse GM-CSF increased the abundance of BrdU+ nuclei by 2.7-fold in 2-wk intimal lesions (Fig. 5 b), indicating that many cells in lesions are capable of proliferating after exposure to GM-CSF. In this experiment, BrdU+ leukocytes were not detected in the circulation. Injection of a function-blocking antibody to GM-CSF reduced the number of proliferating cells in lesions by 4.8-fold (Fig. 5 c). Collectively, our data demonstrate that GM-CSF is critical for intimal cell proliferation in early lesions.
###end p 28
###begin p 29
###xml 0 141 0 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression of GMR&#945; by intimal cells in the LC of the aortic arch and regulation of intimal cell proliferation by GM-CSF in early lesions.</bold>
###xml 448 451 436 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 444 451 432 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 782 785 768 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 778 785 764 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 992 993 974 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
###xml 834 839 <span type="species:ncbi:10090">mouse</span>
###xml 914 919 <span type="species:ncbi:10090">mouse</span>
###xml 1136 1140 <span type="species:ncbi:10090">mice</span>
###xml 1188 1192 <span type="species:ncbi:10090">mice</span>
Expression of GMRalpha by intimal cells in the LC of the aortic arch and regulation of intimal cell proliferation by GM-CSF in early lesions. (a) Analysis of GMRalpha and cell marker gene (CD68, myeloid cells; CD11c, DCs; CD3, T cells; SM22alpha, smooth muscle cells; CD31 and intercellular adhesion molecule 2 [ICAM2], endothelial cells) mRNA levels by real-time PCR in intimal cells harvested from the GC and LC of ascending aortic arches of Ldlr-/- mice fed a CRD for 2 wk. Values represent the GC to LC ratios. The dashed line (value of 1) indicates equal expression in the GC and LC, and ratios of <1 indicate higher expression levels in the LC. In each experiment, RNA from three aortas was pooled and means +/- SEM of three independent experiments are plotted. (b and c) Ldlr-/- mice fed a CRD for 2 wk were injected i.v. with mouse rGM-CSF (GM) or buffer (C, control) and BrdU as indicated in b, or mAb to mouse GM-CSF (alphaGM) or isotype control (C) and BrdU as indicated in c. BrdU+ nuclei in the ascending aorta were enumerated from en face confocal images. Means +/- SEM were derived from seven control and four GM-treated mice (b), and four control and four alphaGM-treated mice (c). *, P < 0.05; **, P < 0.01.
###end p 29
###begin p 30
###xml 720 724 720 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 865 869 865 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1316 1336 1316 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Chapuis et al., 1997</xref>
###xml 1338 1355 1338 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Daro et al., 2000</xref>
###xml 1406 1424 1406 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Inaba et al., 1992</xref>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 1385 1390 <span type="species:ncbi:10090">mouse</span>
Germline genetic manipulations in mouse models are used to investigate molecular atherogenic mechanisms, yet analysis of atherosclerotic lesions in mice typically consists of lesion burden assessment (by staining for accumulated intimal lipid) and evaluation of cell/matrix composition using histological approaches. Leukocyte recruitment and intimal cell proliferation or death can independently result in differences in lesion burden. This study illustrates a practical, sensitive, and reproducible approach for quantifying cellular events in atherosclerosis. BrdU pulse labeling combined with en face confocal microscopy provides quantitative information on intimal cell proliferation, as well as recruitment of Ly-6Chigh blood monocytes within a 24-h window. Using this approach, we showed that proliferation of intimal cells and recruitment of BM-derived Ly-6Chigh monocytes increase progressively from the inception of atherosclerosis. Experiments with PTx suggested that the two processes occur independently of each other and raise the possibility that blockade of recruitment or proliferation individually may result in a compensatory response. Thus, for effective therapy it may be necessary to target both processes. Previously, GM-CSF was reported to function in the differentiation of monocytes to DCs (Chapuis et al., 1997; Daro et al., 2000) and in the proliferation of mouse DC precursors (Inaba et al., 1992). Our current data support an important role for GM-CSF in mediating intimal DC proliferation in early atherosclerotic lesions and suggest that it may be prudent to block functions of this cytokine when administering a therapy for early atherosclerosis that targets monocyte recruitment.
###end p 30
###begin title 31
MATERIALS AND METHODS
###end title 31
###begin title 32

###end title 32
###begin title 33
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice, BrdU labeling, and treatment with PTx, GM-CSF, or antibody to GM-CSF.
###end title 33
###begin p 34
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 248 251 248 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 244 251 244 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr<sup>&#8722;/&#8722;</sup></italic>
###xml 312 333 312 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Lichtman et al., 1999</xref>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 593 598 <span type="species:ncbi:10090">mouse</span>
###xml 651 656 <span type="species:ncbi:10090">mouse</span>
###xml 773 776 <span type="species:ncbi:10116">rat</span>
Wild-type C57BL/6 and Ldlr-/- mice backcrossed >10 generations into the C57BL/6 background obtained from the Jackson Laboratory were bred. All procedures were approved by the University Health Network Animal Care Committee. At 10-12 wk of age, Ldlr-/- males or females were switched to a 1.25% cholesterol diet (Lichtman et al., 1999). In BrdU labeling experiments, mice received a single 0.2-ml i.v. injection of 2 mg BrdU in PBS (BD). In some experiments, BrdU labeling was performed in conjunction with i.v. injection of 2 microg PTx in PBS (Sigma-Aldrich), 0.01 microg/g of body weight of mouse rGM-CSF in 1% FBS (R&D Systems), or 100 microg anti-mouse GM-CSF (functional grade MP1-22E9; eBioscience). Controls were injected with 0.2 ml PBS, 1% FBS, or isotype control rat IgG2a. Peritonitis was induced with 4% thioglycollate (1 ml i.p.; Difco).
###end p 34
###begin title 35
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Flow cytometry studies of BrdU-injected mice.
###end title 35
###begin p 36
Leukocytes obtained from blood or BM of the femur and tibia were stained with PE-anti-CD115 plus biotin-anti-Ly-6C (Biomedicals AG) or biotin-anti-CD19 (BD) mAbs and streptavidin-allophycocyanin (eBioscience). They were then fixed and permeabilized, and DNA was digested with DNase I (Invitrogen) and stained with FITC-anti-BrdU (BrdU detection kit; BD). Data were acquired with a flow cytometer (Cytomics FC500 MPL; Beckman Coulter) and analyzed using FlowJo analysis software (version 7.2.2; Tree Star, Inc.). A hemocytometer (Bright-Line; Hausser Scientific) was used to determine the concentration of blood leukocytes.
###end p 36
###begin title 37
###xml 57 61 <span type="species:ncbi:10090">mice</span>
En face confocal microscopy of aortas from BrdU-injected mice.
###end title 37
###begin p 38
###xml 301 302 301 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 303 304 303 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 590 611 578 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Lichtman et al., 1999</xref>
###xml 393 404 <span type="species:ncbi:3704">horseradish</span>
Aortas were harvested after perfusion fixation (4% paraformaldehyde, 100 mmHg), and the surrounding adipose tissue was dissected after further fixation for 1 h. For detection of BrdU-labeled intimal cells, aortas were permeabilized (0.5% Triton X-100 for 15 min) and incubated sequentially with 0.3% H2O2 (30 min), DNase I (1.5 h at 37degreesC), FITC-conjugated anti-BrdU (18 h at 4degreesC), horseradish peroxidase (HRP)-conjugated anti-FITC (1:300 dilution for 1 h; Abcam), and FITC-tyramide (PerkinElmer). Lipid accumulated in lesions was detected by oil red O (Sigma-Aldrich) staining (Lichtman et al., 1999), and nuclei were counterstained with 2 microg/ml Hoechst 33342 (Invitrogen).
###end p 38
###begin p 39
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
For immunophenotyping of BrdU+ cells, aortas were incubated overnight with FITC-anti-BrdU and biotinylated mAb to CD11b (BD), CD11c, CD45 (eBioscience), 33D1 (BD), or CD68 (AbD Serotec). mAbs to CD11b, CD11c, and CD45 were detected with streptavidin-HRP (1:300 dilution) and cyanine 3-tyramide (PerkinElmer), and others were detected with streptavidin-PE. PE-anti-MHC II (BD) and Alexa Fluor 647-anti-CD11c (BioLegend) were also used. A confocal microscope (FV-1000; Olympus) with a 60x (NA 1.4) oil objective was used to acquire images.
###end p 39
###begin title 40
Real-time PCR.
###end title 40
###begin p 41
###xml 255 282 251 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Jongstra-Bilen et al., 2006</xref>
Enzymatic harvesting of intimal cells, reverse transcription real-time PCR (SYBR green- or FAM-labeled GM-CSF2Ralpha TaqMan MGB probe; Mm00438331_g1; ABI Prism 7900HT; Applied Biosystems), and normalization of data were performed as previously described (Jongstra-Bilen et al., 2006).
###end p 41
###begin title 42
Statistical analyses.
###end title 42
###begin p 43
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Differences between two groups were determined by an unpaired two-tailed t test and analysis of variance followed by Tukey-Kramer multiple comparison tests were used to compare multiple groups.
###end p 43
###begin title 44
Online supplemental material.
###end title 44
###begin p 45
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 319 320 319 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 325 326 325 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 441 442 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows the location of proliferating intimal BrdU+ cells (a-c), and the time course of proliferating BrdU+ nuclei and BrdU+ nuclear doublets (d-f) in 2-wk lesions. Fig. S2 depicts flow cytometry analysis of the peritoneal exudates and blood of PTx-treated and control mice. Fig. S3 shows the distribution of BrdU+CD11c+ proliferating intimal cells costained with CD68 or CD11b in 2-wk lesions. Fig. S4 depicts costaining of BrdU+CD11c+ proliferating intimal cells with MHC II and CD68. Online supplemental material is available at .
###end p 45
###begin title 46
Supplementary Material
###end title 46
###begin title 47
[Supplemental Material]
###end title 47
###begin p 48
We thank the Banting and Best Diabetes Centre and the Toronto General Research Institute for contributing to the purchase of the ABI Prism 7900HT real-time PCR machine.
###end p 48
###begin p 49
This research was supported by the Heart and Stroke Foundation of Ontario (HSFO; grant T-6107). M.I. Cybulsky is a Career Investigator of the HSFO and a member of the Heart and Stroke/Richard Lewar Centre of Excellence at the University of Toronto.
###end p 49
###begin p 50
The authors have no conflicting financial interests.
###end p 50
###begin article-title 51
###xml 19 24 <span type="species:ncbi:9606">human</span>
Differentiation of human dendritic cells from monocytes in vitro.
###end article-title 51
###begin article-title 52
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves.
###end article-title 52
###begin article-title 53
###xml 97 103 <span type="species:ncbi:10090">murine</span>
Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but not CD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand.
###end article-title 53
###begin article-title 54
###xml 108 112 <span type="species:ncbi:10090">mice</span>
GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice.
###end article-title 54
###begin article-title 55
Blood monocytes consist of two principal subsets with distinct migratory properties.
###end article-title 55
###begin article-title 56
A novel method to quantify the turnover and release of monocytes from the bone marrow using the thymidine analog 5'-bromo-2'-deoxyuridine.
###end article-title 56
###begin article-title 57
###xml 17 22 <span type="species:ncbi:9606">human</span>
Heterogeneity of human peripheral blood monocyte subsets.
###end article-title 57
###begin article-title 58
GM-CSF biology.
###end article-title 58
###begin article-title 59
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Identification of proliferating dendritic cell precursors in mouse blood.
###end article-title 59
###begin article-title 60
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice.
###end article-title 60
###begin article-title 61
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 96 103 <span type="species:ncbi:9986">rabbits</span>
Potent cholesterol-lowering effect by human granulocyte-macrophage colony-stimulating factor in rabbits. Possible implications of enhancement of macrophage functions and an increase in mRNA for VLDL receptor.
###end article-title 61
###begin article-title 62
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis.
###end article-title 62
###begin article-title 63
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
###xml 87 90 <span type="species:ncbi:10116">rat</span>
The distribution and fate of bromodeoxyuridine and bromodeoxycytidine in the mouse and rat.
###end article-title 63
###begin article-title 64
###xml 97 103 <span type="species:ncbi:10090">murine</span>
Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model.
###end article-title 64
###begin article-title 65
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate.
###end article-title 65
###begin article-title 66
Macrophage-specific p53 expression plays a crucial role in atherosclerosis development and plaque remodeling.
###end article-title 66
###begin article-title 67
Scavenger receptors in atherosclerosis: beyond lipid uptake.
###end article-title 67
###begin article-title 68
Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events.
###end article-title 68
###begin article-title 69
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
A monoclonal antibody specific for mouse dendritic cells.
###end article-title 69
###begin article-title 70
###xml 49 54 <span type="species:ncbi:9606">human</span>
Cell proliferation in normal and atherosclerotic human aorta: proliferative splash in lipid-rich lesions.
###end article-title 70
###begin article-title 71
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.
###end article-title 71
###begin article-title 72
Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins.
###end article-title 72
###begin article-title 73
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Characterisation of the expression and function of the GM-CSF receptor alpha-chain in mice.
###end article-title 73
###begin article-title 74
###xml 127 134 <span type="species:ncbi:9986">rabbits</span>
Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits.
###end article-title 74
###begin article-title 75
Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions.
###end article-title 75
###begin article-title 76
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
###end article-title 76
###begin article-title 77
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.
###end article-title 77
###begin article-title 78
CXCR2- and E-selectin-induced neutrophil arrest during inflammation in vivo.
###end article-title 78
###begin article-title 79
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease.
###end article-title 79
###begin article-title 80
Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata.
###end article-title 80
###begin article-title 81
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.
###end article-title 81
###begin article-title 82
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Identification of novel dendritic cell populations in normal mouse retina.
###end article-title 82
###begin p 83
###xml 0 19 0 19 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="84">Abbreviations used:</title>
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 19 23 19 23 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Apoe</italic></term>
###xml 23 39 23 39 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="85">apolipoprotein E</p>
###xml 23 39 23 39 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="85">apolipoprotein E</p></def>
###xml 19 39 19 39 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term><italic>Apoe</italic></term><def><p textid="85">apolipoprotein E</p></def></def-item>
###xml 39 42 39 42 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRD</term>
###xml 42 63 42 63 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="86">cholesterol-rich diet</p>
###xml 42 63 42 63 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="86">cholesterol-rich diet</p></def>
###xml 39 63 39 63 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>CRD</term><def><p textid="86">cholesterol-rich diet</p></def></def-item>
###xml 63 65 63 65 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC</term>
###xml 65 82 65 82 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="87">greater curvature</p>
###xml 65 82 65 82 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="87">greater curvature</p></def>
###xml 63 82 63 82 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>GC</term><def><p textid="87">greater curvature</p></def></def-item>
###xml 82 90 82 86 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GMR&#945;</term>
###xml 90 117 86 109 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="88">GM-CSF receptor &#945; chain</p>
###xml 90 117 86 109 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="88">GM-CSF receptor &#945; chain</p></def>
###xml 82 117 82 109 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>GMR&#945;</term><def><p textid="88">GM-CSF receptor &#945; chain</p></def></def-item>
###xml 117 119 109 111 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LC</term>
###xml 119 135 111 127 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="89">lesser curvature</p>
###xml 119 135 111 127 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="89">lesser curvature</p></def>
###xml 117 135 109 127 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>LC</term><def><p textid="89">lesser curvature</p></def></def-item>
###xml 135 138 127 130 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LDL</term>
###xml 138 161 130 153 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="90">low density lipoprotein</p>
###xml 138 161 130 153 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="90">low density lipoprotein</p></def>
###xml 135 161 127 153 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>LDL</term><def><p textid="90">low density lipoprotein</p></def></def-item>
###xml 161 165 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ldlr</italic>
###xml 161 165 153 157 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Ldlr</italic></term>
###xml 165 177 157 169 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="91">LDL receptor</p>
###xml 165 177 157 169 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="91">LDL receptor</p></def>
###xml 161 177 153 169 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term><italic>Ldlr</italic></term><def><p textid="91">LDL receptor</p></def></def-item>
###xml 177 180 169 172 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFI</term>
###xml 180 207 172 199 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="92">mean fluorescence intensity</p>
###xml 180 207 172 199 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="92">mean fluorescence intensity</p></def>
###xml 177 207 169 199 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>MFI</term><def><p textid="92">mean fluorescence intensity</p></def></def-item>
###xml 207 213 199 205 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC II</term>
###xml 213 225 205 217 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="93">MHC class II</p>
###xml 213 225 205 217 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="93">MHC class II</p></def>
###xml 207 225 199 217 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>MHC II</term><def><p textid="93">MHC class II</p></def></def-item>
###xml 225 228 217 220 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTx</term>
###xml 228 243 220 235 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="94">pertussis toxin</p>
###xml 228 243 220 235 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="94">pertussis toxin</p></def>
###xml 225 243 217 235 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>PTx</term><def><p textid="94">pertussis toxin</p></def></def-item>
###xml 243 246 235 238 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCD</term>
###xml 246 264 238 256 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="95">standard chow diet</p>
###xml 246 264 238 256 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="95">standard chow diet</p></def>
###xml 243 264 235 256 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>SCD</term><def><p textid="95">standard chow diet</p></def></def-item>
###xml 0 264 0 256 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="84">Abbreviations used:</title><def-item><term><italic>Apoe</italic></term><def><p textid="85">apolipoprotein E</p></def></def-item><def-item><term>CRD</term><def><p textid="86">cholesterol-rich diet</p></def></def-item><def-item><term>GC</term><def><p textid="87">greater curvature</p></def></def-item><def-item><term>GMR&#945;</term><def><p textid="88">GM-CSF receptor &#945; chain</p></def></def-item><def-item><term>LC</term><def><p textid="89">lesser curvature</p></def></def-item><def-item><term>LDL</term><def><p textid="90">low density lipoprotein</p></def></def-item><def-item><term><italic>Ldlr</italic></term><def><p textid="91">LDL receptor</p></def></def-item><def-item><term>MFI</term><def><p textid="92">mean fluorescence intensity</p></def></def-item><def-item><term>MHC II</term><def><p textid="93">MHC class II</p></def></def-item><def-item><term>PTx</term><def><p textid="94">pertussis toxin</p></def></def-item><def-item><term>SCD</term><def><p textid="95">standard chow diet</p></def></def-item></def-list>
Abbreviations used:Apoeapolipoprotein ECRDcholesterol-rich dietGCgreater curvatureGMRalphaGM-CSF receptor alpha chainLClesser curvatureLDLlow density lipoproteinLdlrLDL receptorMFImean fluorescence intensityMHC IIMHC class IIPTxpertussis toxinSCDstandard chow diet
###end p 83
###begin title 84
Abbreviations used:
###end title 84
###begin p 85
apolipoprotein E
###end p 85
###begin p 86
cholesterol-rich diet
###end p 86
###begin p 87
greater curvature
###end p 87
###begin p 88
GM-CSF receptor alpha chain
###end p 88
###begin p 89
lesser curvature
###end p 89
###begin p 90
low density lipoprotein
###end p 90
###begin p 91
LDL receptor
###end p 91
###begin p 92
mean fluorescence intensity
###end p 92
###begin p 93
MHC class II
###end p 93
###begin p 94
pertussis toxin
###end p 94
###begin p 95
standard chow diet
###end p 95

